Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days.
BACKGROUND
Six percent cellulose sulfate (CS) is a vaginal gel that has been in development as a microbicide.


METHODS
This was a single-center, multi-dose, Phase I, placebo-controlled, randomized, fully masked study conducted in Yaoundé, Cameroon, and involving sexually active women at low risk for sexually transmitted infections (STIs).


METHODS
The study assessed the effect of CS and K-Y Jelly applied vaginally four times per day, for 14 consecutive days, on genital epithelial disruption, candidiasis and bacterial vaginosis (BV). Acceptability of the products was also assessed. Twenty-seven women were enrolled in each treatment group.


RESULTS
Two (7.4%) of the women in each group developed genital epithelial disruption. One (3.7%) of the women in each group developed candidiasis, and one (3.7%) of the K-Y users developed BV. One (3.7%) of the CS users said she would not buy her product for pregnancy prevention but would for STI prevention. All the remaining women indicated they would buy their product for both indications.


CONCLUSIONS
The results suggest that the safety and acceptability of 6% CS gel are comparable to that of K-Y Jelly.
Doh
Anderson S
AS
l'Hôpital Gynéco Obstétrique et Pédiatrique de Yaoundé, Yaoundé, Cameroon.
Ngoh
Nkele
N
Roddy
Ron
R
Lai
Jaim-Jou
JJ
Linton
Kim
K
Mauck
Christine
C
D000328:Adult; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage* / Q000009:adverse effects; D002181:Candidiasis, Vulvovaginal / Q000209:etiology; D002482:Cellulose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004848:Epithelium / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D010342:Patient Acceptance of Health Care; D010349:Patient Compliance; D012749:Sexually Transmitted Diseases / Q000517:prevention & control; D014621:Vagina / Q000187:drug effects*; D014622:Vaginal Creams, Foams, and Jellies / Q000009:adverse effects; D016585:Vaginosis, Bacterial / Q000209:etiology
D000891:Anti-Infective Agents, Local; D014622:Vaginal Creams, Foams, and Jellies; D002482:Cellulose; C020254:cellulose sulfate